Bio-Pharm

The government has selected the ‘Korea Value Up’ Index as part of its efforts to address the Korea Discount, and 12…

Lunit, a leading medical AI company focused on developing solutions that extend beyond diagnosis into treatment, is…

Yuhan Corporation announced on the 11th that it will receive $60 million (approximately 80 billion KRW) in…

The U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for the…

Park Jaehyun, CEO of Hanmi Pharmaceutical, retained his position following a board decision that rejected the…

SK Biopharmaceuticals has set an ambitious goal to emerge as a global player in the radiopharmaceutical(RPT) sector…

Celltrion has signed a listing agreement for Zymfentra with the major U.S. insurer Cigna, following its successful…

There is a growing consensus that aesthetic-focused companies, which demonstrated strong stock performance in Q2, will…

Voronoi, a drug development specialist that recently licensed out its autoimmune disease treatment pipeline to a…

"When coincidences accumulate, they become inevitable. The fact that LECLAZA, which I once crossed paths with, came back…

Celltrion announced on the 12th that it has received approval from the U.S. Food and Drug Administration (FDA) for the…

Daewoong Pharmaceutical achieved its highest-ever quarterly performance in Q2, driven by a focus on new drugs and an…

Market expectations are rising for Hugel following its announcement of results that far exceeded projections. Analysts…

There is a prediction in the securities industry that GC, which showed poor performance in Q2 this year, will succeed in…

Celltrion's 'Zymfentra', has been successfully listed in the formularies of all three major Pharmacy Benefit Managers…

The obesity treatment drug 'Mounjaro' (active ingredient: tirzepatide), which has shown powerful weight loss effects…

Samsung, which ambitiously announced its expansion into the healthcare sector, is now facing a significant problem with…

Hanmi Pharmaceutical has achieved robust performance due to strong sales of key products and the growth of its…

Daewoong Pharmaceutical announced on the 29th that its new drug 'Bersiporocin', currently being developed as the world's…

ST Pharm, which recorded a deficit in the first half of the year, is expected to see a rebound in performance in the…